Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.

Literature DB >> 17168998

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.

Abstract

At the end of 2005, six European countries had implemented public immunization campaigns with serogroup C conjugate vaccines, and all had experienced substantial declines in the incidence of serogroup C disease. A quadrivalent ACWY meningococcal vaccine is in use in the USA, but serogroup A is extremely rare in Europe and serogroups Y and W135 are infrequent causes of disease. This paper outlines recommendations on the use of conjugate vaccines in Europe based on the experience with meningococcal C conjugate (MCC) vaccines so far.

Entities: Disease

Mesh：

Substances：

Year: 2006 PMID： 17168998 DOI： 10.1111/j.1574-6976.2006.00053.x

Source DB: PubMed Journal: FEMS Microbiol Rev ISSN： 0168-6445 Impact factor: 16.408

Keyword Cloud
Cited

56 in total

1. Epidemiology of invasive meningococcal disease in Austria 2010.

Authors: Georg Steindl; Yu-Lun Liu; Daniela Schmid; Ulrike Orendi; Andrea Kormann-Klement; Sigrid Heuberger
Journal: Wien Klin Wochenschr Date: 2011-09-26 Impact factor: 1.704

2. Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.

Authors: C Hal Jones; Naglaa Mohamed; Eduardo Rojas; Lubomira Andrew; Johanna Hoyos; Julio C Hawkins; Lisa K McNeil; Qin Jiang; Leonard W Mayer; Xin Wang; Rodica Gilca; Philippe De Wals; Louise Pedneault; Joseph Eiden; Kathrin U Jansen; Annaliesa S Anderson
Journal: J Clin Microbiol Date: 2015-08-26 Impact factor: 5.948

3. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.

Authors: Jian-li Hu; Hong Tao; Jing-xin Li; Wei-ming Dai; Bin Song; Jin-fang Sun; Pei Liu; Jie Tang; Wen-yu Liu; Shi-yuan Wang; Feng-cai Zhu
Journal: Hum Vaccin Immunother Date: 2015 Impact factor: 3.452

4. Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus.

Authors: Eduardo Lujan; Kathleen Winter; Jillandra Rovaris; Qin Liu; Dan M Granoff
Journal: Clin Infect Dis Date: 2017-10-01 Impact factor: 9.079

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.

1. Epidemiology of invasive meningococcal disease in Austria 2010.

2. Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.

3. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.

4. Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus.

Review 5. Review of meningococcal vaccines with updates on immunization in adults.

Review 6. Epidemiological profile of meningococcal disease in the United States.

Review 7. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease.

8. The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.

Review 9. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

10. Serogroup C meningococci in Italy in the era of conjugate menC vaccination.